BU-NOT-SET

CONTACT US
Fixed dose combinations - for improved patient compliance
  • Drug product
mini-tablets
Fact sheet
The current state of contract manufacturing
  • Industry trends
Eyes
Insight
The potential impact of Brexit on patient safety
  • Industry trends
Eyes
Insight
EU FMD: After the deadline
  • Manufacturing
Eyes
Insight
The importance of supply chain security
  • Manufacturing
Eyes
Insight
ADC development: setbacks and key developments
  • Drug substance
Lab equipment
Insight
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
  • Drug substance
Eyes
Insight
CDMO trends: Drug development and industry consolidation
  • Industry trends
Eyes
Insight
Consolidation in the CDMO Market
  • Industry trends
Eyes
Insight
Webinar
  • Drug product
  • Manufacturing
Blow-fill-seal transforming distribution of biologics and vaccines
Insight
  • Drug product
  • Industry trends
Key factors and trends driving innovation in drug dosage forms
Insight
  • Sustainability
Water matters: How cutting back reduced Pianezza’s greenhouse gas emissions
Insight
  • Biologics
The evolving mRNA landscape
Insight
  • Sustainability
How can the pharmaceutical industry reduce its carbon footprint?
Insight
  • Biologics
Regulatory challenges in gene therapy manufacturing
Webinar
  • Drug product
Reformulation strategies to enhance and extend your drug product success
Insight
  • Biologics
Gene therapy manufacturing journey
Insight
  • Biologics
Pushing boundaries in mRNA vaccine manufacturing